Satsuma Pharmaceuticals Current Ratio 2020-2023 | STSA
Satsuma Pharmaceuticals current ratio from 2020 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-03-31 | $0.04B | $0.01B | 7.44 |
| 2022-12-31 | $0.06B | $0.01B | 6.75 |
| 2022-09-30 | $0.07B | $0.01B | 10.15 |
| 2022-06-30 | $0.07B | $0.01B | 9.18 |
| 2022-03-31 | $0.08B | $0.01B | 12.77 |
| 2021-12-31 | $0.10B | $0.01B | 11.76 |
| 2021-09-30 | $0.11B | $0.01B | 16.61 |
| 2021-06-30 | $0.13B | $0.01B | 16.66 |
| 2021-03-31 | $0.14B | $0.01B | 25.50 |
| 2020-12-31 | $0.07B | $0.01B | 9.17 |
| 2020-09-30 | $0.09B | $0.01B | 11.71 |
| 2020-06-30 | $0.10B | $0.01B | 15.11 |
| 2020-03-31 | $0.11B | $0.01B | 15.05 |
| 2019-12-31 | $0.12B | $0.01B | 14.40 |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2019-03-31 | $0.00B | 0.00 | |
